According to reports the National Institute of Health and Clinical Excellence (Nice) has planned new guidelines concerning osteoporosis treatments.
People suffering from osteoporosis (porous bones) are at higher risk of fractures. The existing treatments enhance bone density in order to prevent fragile bones.
Post menopausal women at any age are given bisposphanates and strontium ranelate. But Nice wants to execute guidelines according to which, only women above the age of 75 would be entitled to the drugs on the NHS.
Nice provides guidance on drugs that should be made available on the NHS and this draft guidance will undergo a consultation process.